M Hrubý

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Endogenous Erythropoietin Levels and Anemia in Long-Term Renal Transplant Recipients

Josef Zadražil, Pavel Hořák, Vladko Horčička et al. · Kidney & Blood Pressure Research · 2007 · 20 citations

Medicine, Hematology, Nephrology +14

Cutaneous bacillary angiomatosis due to<i>Bartonella quintana</i>in a renal transplant recipient

Jiří Orság, Patrik Flódr, Oto Melter et al. · Transplant International · 2015 · 18 citations

Life Sciences, Infectious Diseases, Microbiology +13

Idiopathic myelofibrosis complicated by portal hypertension treated with a transjugular intrahepatic portosystemic shunt (TIPS).

Jan Bělohlávek, Johannes Schwarz, A Jirásek et al. · PubMed · 2001 · 18 citations

Medicine, Hematology, Internal Medicine +15

Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients

Petr Kosztyu, Martin Hill, Jana Jemelkova et al. · Kidney & Blood Pressure Research · 2018 · 17 citations · Full text

Life Sciences, Immunology, Nephrology +17